Related Experiment Video
Updated: Aug 26, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Interactions of decay-accelerating factor (DAF) with haemagglutinating human enteroviruses: utilizing variation in
David T Williams1, Yasmin Chaudhry1, Ian G Goodfellow1
1Faculty of Biomedical and Life Sciences, Division of Virology, University of Glasgow, Glasgow G11 5JR, UK.
Abstract:
A cellular receptor for the haemagglutinating enteroviruses (HEV), and the protein that mediates haemagglutination, is the membrane complement regulatory protein decay accelerating factor (DAF; CD55). Although primate DAF is highly conserved, significant differences exist to enable cell lines derived from primates to be utilized for the characterization of the DAF binding phenotype of human enteroviruses. Thus, several distinct DAF-binding phenotypes of a selection of HEVs (viz. coxsackievirus A21 and echoviruses 6, 7, 11-13, 29) were identified from binding and infection assays using a panel of primate cells derived from human, orang-utan, African Green monkey and baboon tissues. These studies complement our recent determination of the crystal structure of SCR(34) of human DAF [Williams, P., Chaudhry, Y., Goodfellow, I. G., Billington, J., Powell, R., Spiller, O. B., Evans, D. J. & Lea, S. (2003). J Biol Chem 278, 10691-10696] and have enabled us to better map the regions of DAF with which enteroviruses interact and, in certain cases, predict specific virus-receptor contacts.

